Vaccine sentiment boost - behind the headlines
The COVID-19 vaccine news has quashed Monday's risk off tone, with Moderna's trial helping to put a bid back into the risk asset spectrum and S&P futures gapping higher on the news. Sentiment was beginning to look very fatigued and the positive catalyst was much needed to propel risk on moves across Asia today.
Liquidity driven narrative remains intact but Gold knows there is no V-shaped recovery
Stocks trade mixed in Asia following a positive overnight lead with the Nasdaq 100 hitting a fresh record high. This as US indices closed off the highs of session following a continued rise in COVID-19 cases with hospitalisations also continuing to pick up largely in Southern States. COVID-19 patients in Texas hospitals have risen 61% in one week, threatening the prospect of a swift snapback in activity if restrictions are reimposed once more.